Top Page
Ehealth
(NASDAQ:EHTH)
Ehealth (EHTH) vs. SPDR S&P 500 ETF (SPY)
Ehealth Business Overview & Revenue Model
Ehealth Earnings Call Summary
Ehealth Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 547.49M | 532.41M | 452.87M | 405.36M | 538.20M | 582.77M |
| Gross Profit | 547.49M | 530.62M | 451.10M | 403.71M | 536.21M | 578.69M |
| EBITDA | 71.34M | 46.81M | 295.00K | -77.65M | -105.18M | 66.27M |
| Net Income | 39.56M | 10.06M | -28.21M | -88.72M | -104.38M | 45.45M |
Balance Sheet | ||||||
| Total Assets | 1.08B | 1.16B | 1.11B | 1.11B | 1.15B | 1.04B |
| Cash, Cash Equivalents and Short-Term Investments | 105.20M | 82.24M | 121.65M | 144.40M | 123.23M | 93.38M |
| Total Debt | 93.76M | 96.92M | 103.16M | 106.80M | 41.37M | 46.56M |
| Total Liabilities | 165.88M | 229.49M | 209.26M | 198.37M | 167.18M | 202.46M |
| Stockholders Equity | 913.83M | 925.94M | 904.08M | 914.24M | 982.11M | 837.56M |
Cash Flow | ||||||
| Free Cash Flow | -30.13M | -31.22M | -17.47M | -42.38M | -183.48M | -131.62M |
| Operating Cash Flow | -21.03M | -18.37M | -6.69M | -26.87M | -162.62M | -107.86M |
| Investing Cash Flow | -29.33M | -48.42M | -15.89M | 25.86M | -12.63M | -73.28M |
| Financing Cash Flow | -9.98M | -9.67M | -6.22M | 63.84M | 213.24M | 201.25M |
Ehealth Technical Analysis
Ehealth Risk Analysis
Ehealth Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
61 Neutral | $37.23M | 16.00 | 4.56% | ― | 19.30% | -17.56% | |
59 Neutral | $344.73M | ― | 10.66% | ― | 15.50% | ― | |
58 Neutral | $154.31M | ― | 4.45% | ― | 16.19% | 89.75% | |
43 Neutral | $27.78M | ― | -11.18% | ― | 624.24% | 85.46% | |
41 Neutral | $71.31M | ― | -13.38% | ― | 17.46% | 60.17% | |
40 Underperform | $3.76M | ― | -223.86% | ― | 1.07% | 96.67% |
Ehealth Corporate Events
On October 6, 2025, eHealth, Inc. announced an amendment to its credit agreement with Blue Torch Finance LLC, extending the maturity date of its term loan to January 29, 2027. This extension is part of eHealth’s strategy to enhance its capital structure, providing financial flexibility to support its strategic initiatives and long-term success. The company aims to leverage its commissions receivable asset to increase capital access and address its convertible Series A preferred stock instrument, demonstrating a commitment to optimizing its capital structure and maximizing shareholder value.
The most recent analyst rating on (EHTH) stock is a Hold with a $5.50 price target. To see the full list of analyst forecasts on Ehealth stock, see the EHTH Stock Forecast page.
On September 17, 2025, Aaron Tolson resigned from the Board of Directors of eHealth, Inc., along with its various committees, and was replaced by Todd Arden, a designee of Echelon Health SPV, LP, under the terms of an existing Investment Agreement. Additionally, Derrick Duke was appointed as a new director, increasing the total number of directors from nine to ten. Both appointments are effective immediately and will last until the 2028 annual meeting of stockholders. These changes are part of the company’s ongoing governance adjustments, with no disagreements or undisclosed relationships involved.
The most recent analyst rating on (EHTH) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Ehealth stock, see the EHTH Stock Forecast page.
The recent earnings call for eHealth presented a balanced sentiment, highlighting both achievements and challenges. The company demonstrated strong revenue growth and strategic advancements, notably with the successful AI pilot and improved retention strategies. However, it also faced hurdles such as a GAAP net loss and regulatory impacts on enrollment figures, creating a mixed but overall optimistic outlook.
eHealth, Inc., a prominent online health insurance marketplace, specializes in connecting consumers with a wide range of health insurance plans, focusing primarily on Medicare-related products. In its second quarter of 2025, eHealth reported a total revenue of $60.8 million, marking an 8% decrease from the previous year. Despite this decline, the company saw an improvement in its net loss, which reduced to $17.4 million from $28.0 million in the same quarter of 2024. The company also reported a positive net adjustment revenue of $17.8 million, up from $11.5 million in the previous year. Operating costs and expenses were reduced by 11%, and there was a notable 24% reduction in variable marketing spend within the Medicare segment. eHealth’s strategic focus on customer loyalty and direct branded channels contributed to a 29% increase in the constrained lifetime value of Medicare Supplement commissions. Looking ahead, eHealth has raised its 2025 annual revenue and earnings guidance, reflecting confidence in its strategic positioning and the anticipated opportunities in the upcoming Medicare Annual Enrollment Period.
On July 29, 2025, eHealth, Inc. announced the appointment of Derrick Duke as its new Chief Executive Officer, succeeding Fran Soistman, who will retire but remain on the Board of Directors. Duke, who brings extensive experience from his previous role as CEO of Magellan Health, will join eHealth on August 4, 2025, to begin the transition process, officially taking over as CEO on September 18, 2025. This leadership change is expected to drive eHealth into its next phase of growth, leveraging Duke’s financial acumen and operational expertise to continue delivering value to customers and stakeholders.
The most recent analyst rating on (EHTH) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Ehealth stock, see the EHTH Stock Forecast page.